Clinical Trials in California

Showing 9281-9300 of 11,359 trials

Pegylated Liposomal Doxorubicin, Bortezomib, Dexamethasone and Lenalidomide for Relapsed/Refractory Multiple Myeloma

NCT01160484

This is a phase II, multicenter, open label, nonrandomized study to evaluate the efficacy and safety of lenalidomide at a dose of 10 mg/dose in combination with bortezomib at 1.0 mg/m2/dose, pegylated liposomal doxorubicin (PLD) at 4.0 mg/m2/dose, and intravenous (IV) dexamethasone at 40 mg/dose in adult patients with relapsed/refractory multiple myeloma (MM). The study consists of a screening period, followed by up to eight 28 day open label treatment cycles, a final assessment to occur 28 days after the end of the last treatment cycle, and a follow-up period.

Multiple Myeloma

Oncotherapeutics40 participantsStarted Sep 2009

Bakersfield, California, United States • Fresno, California, United States • Loma Linda, California, United States +5 more locations

COMPLETEDPhase 344 miles

A Trial of an Oral Nutritional Supplement in Older Hospitalized Patients - NOURISH Study

NCT01626742

Evaluate effects of an oral nutritional supplement on healthcare outcomes in older hospitalized adults. Also referred to as the NOURISH Study - Nutrition effect On Unplanned Readmissions and Survival in Hospitalized patients.

Hospitalized Elderly

Abbott Nutrition652 participantsStarted May 2012

Auburn, Alabama, United States • Birmingham, Alabama, United States • Huntsville, Alabama, United States +116 more locations

Pegylated Liposomal Doxorubicin, Bortezomib, Dexamethasone and Lenalidomide for Relapsed/Refractory Multiple Myeloma

A Trial of an Oral Nutritional Supplement in Older Hospitalized Patients - NOURISH Study

Find Trials by Condition in California

Safety of Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus Treated With Thiazolidinedione Alone or Thiazolidinedione in Combination With Metformin

A Study of LY2189265 Compared to Sitagliptin in Participants With Type 2 Diabetes Mellitus on Metformin

Study to Evaluate the Efficacy of Rotigotine on Parkinson's Disease-Associated Pain

15 Month Study for Adults Who Have Been Diagnosed With Schizophrenia and Incarcerated

Study Of Denagliptin In Subjects With Type 2 Diabetes Mellitus (T2DM)

Accelerometer-linked Online Intervention to Promote Physical Activity in Adolescents

CSP #512 - Options in Management With Anti-Retrovirals

Sipuleucel-T as Neoadjuvant Treatment in Prostate Cancer

A Safety and Tolerability Study of Clofarabine, Etoposide, Cyclophosphamide, PEG-asparaginase, and Vincristine in Pediatric Acute Lymphoblastic Leukemia (ALL)

Study to Evaluate the Safety, Tolerability and Efficacy of Three Dose Levels of Mitoglitazone in Type 2 Diabetic Patients

A Study of Fluzone® High-Dose Vaccine Compared With Fluzone® Vaccine In Elderly Adults

Study Evaluating ERB-041 in Endometriosis in Reproductive-Age Women

LMB-2 Immunotoxin in Treating Young Patients With Relapsed or Refractory Leukemia or Lymphoma

Ketoconazole, Hydrocortisone and Dutasteride in Asymptomatic Hormone Refractory Prostate Cancer

A Comparative Study Of Iodine I 131 Tositumomab Therapeutic Regimen Versus Ibritumomab Tiuxetan Therapeutic Regimen

Patient-Centered Adherence Intervention After Acute Coronary Syndrome (ACS) Hospitalization

Zyban as an Effective Smoking Cessation Aid for Patients Following an Acute Coronary Syndrome: The ZESCA Trial

A Study of Retreatment With MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis (RA)